Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 65.18M P/E - EPS this Y 3.00% Ern Qtrly Grth -
Income -58.21M Forward P/E -1.27 EPS next Y -31.00% 50D Avg Chg -12.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -12.00%
Dividend N/A Price/Book 0.51 EPS next 5Y - 52W High Chg -47.00%
Recommedations 1.70 Quick Ratio 11.50 Shares Outstanding 55.37M 52W Low Chg 32.00%
Insider Own 11.51% ROA -34.67% Shares Float 31.30M Beta 1.19
Inst Own 71.69% ROE -58.75% Shares Shorted/Prior 1.05M/1.32M Price 1.77
Gross Margin - Profit Margin - Avg. Volume 23,227 Target Price 12.33
Oper. Margin - Earnings Date Nov 11 Volume 46,141 Change 0.57%
About Rezolute, Inc.

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. The company's lead product candidate is ersodetug, a human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 2 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.

Rezolute, Inc. News
11/13/24 We Think Rezolute (NASDAQ:RZLT) Needs To Drive Business Growth Carefully
11/07/24 Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
11/05/24 Rezolute to Participate in Upcoming Investor Conferences
10/17/24 With 62% ownership, Rezolute, Inc. (NASDAQ:RZLT) boasts of strong institutional backing
09/19/24 Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update
09/09/24 FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study
09/03/24 Pleasing Signs As A Number Of Insiders Buy Rezolute Stock
08/05/24 Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
07/31/24 Rezolute to Participate in the BTIG Virtual Biotechnology Conference
06/27/24 Rezolute Announces Exercise of Underwritersโ€™ Option to Purchase Additional Shares and Concurrent Private Placement
06/24/24 Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds
06/13/24 Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants
06/13/24 Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
05/30/24 Rezolute to Participate in the Jefferies Global Healthcare Conference
05/21/24 Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)
05/15/24 Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
05/10/24 Rezolute, Inc. (NASDAQ:RZLT) has caught the attention of institutional investors who hold a sizeable 47% stake
04/23/24 Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting
03/27/24 Rezolute Reaches US$75m Market Cap Benefiting Insider Stock Buying
03/06/24 Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)
RZLT Chatroom

User Image oaksapollo Posted - 3 days ago

$RZLT now would be a good time to announce a deal on the DME drug

User Image NVDAMillionaire Posted - 4 days ago

$RZLT Rezolute, Inc. (NASDAQ: RZLT): Pioneering Transformative Therapies for Rare Diseases https://beyondspx.com/article/rezolute-inc-rzlt-transforming-metabolic-diseases-with-promising-pipeline

User Image oaksapollo Posted - 1 week ago

$RZLT Stonepine sold out. Wonder why... https://ir.stockpr.com/rezolutebio/sec-filings-email/content/0000935836-24-000666/rzlt13ga4.htm

User Image TrendsetterTrading Posted - 1 week ago

$RZLT beat the crowd! Follow for calls and charting ideas ๐Ÿ’ก

User Image jacksparo Posted - 1 week ago

$RZLT Another successful one in my book 2024 โœ…๐Ÿ“ˆ

User Image swingingtech Posted - 2 weeks ago

$RZLT https://wallstreetwaves.com/wedbush-initiates-coverage-of-rezolute-rzlt-with-outperform-recommendation/

User Image erevnon Posted - 2 weeks ago

Wedbush initiates coverage on Rezolute $RZLT at Outperform rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image Capitulation_0 Posted - 10/30/24

$RZLT A lot of funds are high on this name. You know it's on BPs radar as well. cHI is much bigger indication than people think. BP's are looking for smaller deals. This one makes sense.

User Image Capitulation_0 Posted - 10/29/24

$RZLT setting up for next leg up. Should be trading near 1B valuation.

User Image Capitulation_0 Posted - 10/29/24

$RZLT Best in class rare disease for a 300m MC. MRK, PFE, ABBV could all use a first mover indication to bolster up their portfolio. 600m to generate 1B in revenue in few years. I don't understand the lack of deal making by BPs.

User Image JoshThe3rd Posted - 10/28/24

$ATYR $RZLT looks like adding on MA dips might be the strategy for these tickers into catalysts.

User Image Capitulation_0 Posted - 10/28/24

$RZLT CEO has history of M&A. Founded several companies. Uncrowded space. 2 shots on goal. Partial clinical hold recently lifted. Should be trading double/triple current valuation

User Image Capitulation_0 Posted - 10/28/24

$RZLT should be trading much higher. Just getting started imo. Rare disease w/o competition and unmet need can be much priced very favorably. While it's a small market, it can generate substantial revenue regardless. Kimmtrak w/ 1000 pool generated 300m/yr after 3 years post approval for end of life disease.

User Image PenkeTrading Posted - 10/26/24

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Rezolute Inc. Is that bullish or bearish? $RZLT #Rezolute #RsiOverbought #NASDAQ

User Image Capitulation_0 Posted - 10/25/24

$RZLT should be trading near $20 with clinical hold off.. Price discovery for bios is way the hell off.

User Image jacksparo Posted - 10/24/24

$RZLT Since March this year and I am still holding ๐Ÿ“ˆ

User Image jacksparo Posted - 10/24/24

$RZLT Successful long term spot for me in 2024 so far !โœ…โœ…๐Ÿ“ˆ

User Image PLATINUM_TRADES Posted - 10/23/24

$RZLT $5.50 high I told u... Look๐Ÿ‘‡

User Image PLATINUM_TRADES Posted - 10/23/24

$RZLT oh boy this was beautiful $5.50 coming up ๐Ÿ‘†

User Image PLATINUM_TRADES Posted - 10/23/24

$RZLT I gold u where I was adding! Beautiful bounce and overnight swing winner.... $5.50 possible ๐Ÿ™†

User Image PLATINUM_TRADES Posted - 10/23/24

$RZLT adds!!

User Image oaksapollo Posted - 4 weeks ago

$RZLT something is afoot here, big AH vol and more gains. Holding 75k shares.

User Image PLATINUM_TRADES Posted - 4 weeks ago

$RZLT awesome day today but we keeping it.. This has much more... $5.85 next leg up but $5.50 has weak resistance from September so let's get through that first๐Ÿ”ฎ๐Ÿ”ฎ๐Ÿ”ฎ๐Ÿ”ฎ

User Image jacksparo Posted - 4 weeks ago

$RZLT Strong close for my long term one here ๐Ÿ“ˆโœ…

User Image Doozio Posted - 4 weeks ago

$RZLT da FUTUre of ๐Ÿง โฐ is NOW during ๐Ÿง โฐโ™พ๏ธ

User Image Cello69 Posted - 4 weeks ago

$RZLT LFG!!!!

User Image Cello69 Posted - 4 weeks ago

$RZLT What's with the heavy volume today??? AH's news perhaps?

User Image StockHawg Posted - 1 month ago

$RZLT 67K shares roughly traded afterhours. HMM TIKTOK

User Image Cello69 Posted - 1 month ago

$RZLT 16,000 shares traded !!! LOL

User Image oaksapollo Posted - 1 month ago

@DaBullRunner hey people $RZLT and $RZLV are different.

Analyst Ratings
Maxim Group Buy Aug 6, 24
HC Wainwright & Co. Buy Aug 6, 24
BTIG Buy Jul 17, 24
Craig-Hallum Buy Jun 4, 24
HC Wainwright & Co. Buy May 22, 24
HC Wainwright & Co. Buy May 16, 24
JMP Securities Market Outperform Apr 19, 24
JMP Securities Market Outperform Apr 18, 24
JonesTrading Buy Apr 18, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
ROBERTS BRIAN KENNETH Chief Medical Office.. Chief Medical Officer Jul 03 Buy 1.8999 5,000 9,500 27,552 07/06/23
ROBERTS BRIAN KENNETH Sr VP, Clinic Develo.. Sr VP, Clinic Development May 04 Buy 3.80 21,052 79,998 21,052 05/06/22
Labrucherie Gil M Director Director May 04 Buy 3.80 52,631 199,998 52,631 05/06/22
Hogenhuis Wladimir Director Director Oct 15 Buy 5.15 32,693 168,369 32,693 05/06/22